Why the study?
Does initial fixed-dose combination therapy with A/B reduce time to goal BP compared with E monotherapy in African Americans with hypertension and type 2 diabetes mellitus?
RCT (n=265)
Double-blind
randomized
Yes
Does initial fixed-dose combination therapy with A/B reduce time to goal BP compared with E monotherapy in African Americans with hypertension and type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
Initial fixed-dose combination therapy with A/B achieved more rapid and substantial reductions in BP compared with E monotherapy in African Americans with hypertension and type 2 diabetes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fei He (2004) conducted an RCT in Hypertension and type 2 diabetes mellitus (n=265). A/B vs. E 10 mg uptitrated to 20 mg was evaluated on Time to goal BP (p=0.0115).
Synapse has enriched 10 related papers. Consider them for comparative context: